Author:
Kwon Soon-Il,Lee Dae-Hyoung,Kim Yun-Jeong
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Reference5 articles.
1. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031–1037.
2. Pietras K, Östman A, Sjöquist M, et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 2001;61:2929–2934.
3. Fraunfelder FW, Solomon J, Druker BJ, et al. Ocular side effects in chronic myeloid leukemia patients treated with associated with imatinib mesylate (Gleevec). J Ocul Pharmacol Ther 2003;19:371–375.
4. Kusumi E, Arakawa A, Kami M, et al. Visual disturbance due to retinal edema as a complication of imatinib. Leukemia 2004;18:1138–1139.
5. Babu KG, Attili VSS, Bapsy PP, Anupama G. Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia. Int Ophthalmol 2007;27:43–44.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献